title: Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
abstract: Co-amorphous formulations, particularly binary drug-amino acid mixtures, have been shown to provide enhanced dissolution for poorly-soluble drugs and improved physical stability of the amorphous state. However, to date the dissolution properties (mainly intrinsic dissolution rate) of the co-amorphous formulations have been tested only in buffers and their supersaturation ability remain unexplored. Consequently, dissolution studies in simulated intestinal fluids need to be conducted in order to better evaluate the potential of these systems in increasing the oral bioavailability of biopharmaceutics classification system class II drugs. In this study, solubility and dissolution properties of the co-amorphous simvastatin-lysine, gibenclamide-serine, glibenclamide-threonine and glibenclamide-serine-threonine were studied in phosphate buffer pH 7.2 and biorelevant media (fasted and fed state simulated intestinal fluids (FaSSIF and FeSSIF, respectively)). The co-amorphous formulations were found to provide a long-lasting supersaturation and improve the dissolution of the drugs compared to the crystalline and amorphous drugs alone in buffer. Similar improvement, but in lesser extent, was observed in biorelevant media suggesting that a dissolution advantage observed in aqueous buffers may overestimate the advantage in vivo. However, the results show that, in addition to stability advantage shown earlier, co-amorphous drug-amino acid formulations provide dissolution advantage over crystalline drugs in both aqueous and biorelevant conditions.
authors.forename: A T
authors.initials: AT
authors.lastname: Heikkinen
authors.forename: L
authors.initials: L
authors.lastname: DeClerck
authors.forename: K
authors.initials: K
authors.lastname: Löbmann
authors.forename: H
authors.initials: H
authors.lastname: Grohganz
authors.forename: T
authors.initials: T
authors.lastname: Rades
authors.forename: R
authors.initials: R
authors.lastname: Laitinen
mesh_terms: D000596:Amino Acids / Q000737:chemistry*; D001682:Biological Availability; D002021:Buffers; D002626:Chemistry, Pharmaceutical; D004339:Drug Compounding; D006863:Hydrogen-Ion Concentration; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012995:Solubility
chemical_list: D000596:Amino Acids; D002021:Buffers; D004364:Pharmaceutical Preparations